Home Tags Biotech

Tag: Biotech

A sign marks a Biogen facility in Cambridge.

Biogen is crashing after scrapping its late-stage Alzheimer’s drug trials

Biogen shares crashed more than 25% in pre-market trading after discontinuing two late-stage Alzheimer's drug trials with Eisai.
A Memphis Meats chicken strip.

Silicon Valley startups backed by celebrities like Bill Gates are using gene-editing tool Crispr to make meat without farms — and to disrupt a $...

Startups backed by celebrities like Bill Gates and Richard Branson are experimenting with gene-editing to make lab-grown chicken, pork, and beef. It's the first known instance of Crispr being used in a new meat product.
Swedish pharma billionaire Frederik Paulsen made this year's Forbes list.

Meet the 10 richest billionaires in healthcare, whose ranks include a doctor and heirs to pharmaceutical empires

Forbes just released its ranking of the world's richest billionares. Here are the 10 richest billionaires in healthcare and biotech.
Carolyn Barrett, who was born with the rare disease spinal muscular atrophy, and her service dog Shadow head down to the Boston Common in February of 2017. A new gene therapy for spinal muscular atrophy could be approved this year, and may cost up to $5 million for a one-time treatment.

Drugs that cost as much as a house are on the way to treat rare and devastating diseases. The US is scrambling to figure out how to pay for them.

The cost of gene therapies will put a huge financial strain on the US health system as new products become available to treat more common diseases.

Dispensed: Pharma CEOs on Capitol Hill, the exploding CBD market, and treating kids with new models of primary care

Welcome to Dispensed, Business Insider's weekly newsletter giving you a dose of pharma, biotech, and healthcare news.

Dispensed: Pharma’s plan to go beyond drugs, erectile dysfunction medications for young men, and what privacy you have when you take a genetics ...

Welcome to Dispensed, Business Insider's weekly newsletter giving you a dose of pharma, biotech, and healthcare news.

Here’s why Big Pharma is cheering a new proposal from the Trump administration that’s supposed to tackle high drug prices

The proposal is designed to lower costs for patients, but it doesn't require pharma companies to cut the prices of their drugs.

Dispensed: The problem with insulin prices, dispatches from Davos, and the plan to get anti-aging drugs approved

Welcome to Dispensed: a weekly dose of pharma, biotech, and healthcare news.

The CEO of a startup aimed at harnessing the benefits of young blood shares his real plan to beat aging

A startup called Alkahest is studying the anti-aging effects of young blood to design drugs that could fight age-related diseases like Alzheimer's and Parkinson's.

We’ll get you caught up on all the news you missed at the year’s biggest healthcare investor conference

Among the highlights: an $8 billion deal (and more to come?), a promising depression drug, and a strategy deep dive from a healthcare giant.